We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

83 hedge funds and large institutions have $208M invested in Immunomedics Inc in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

52% more call options, than puts

Call options by funds: $15M | Put options by funds: $9.83M

29% more capital invested

Capital invested by funds: $162M → $208M (+$46.8M)

5% more funds holding

Funds holding: 7983 (+4)

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
2.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
28
Reduced
28
Closed
7
Calls
$15M
Puts
$9.83M
Net Calls
+$5.16M
Net Calls Change
+$4.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$881K -$593K -103,000 -44%
Deutsche Bank
27
Deutsche Bank
Germany
$864K -$275K -47,743 -25%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$816K +$23.9K +4,147 +3%
RFC
29
Russell Frank Company
Washington
$765K -$142K -24,707 -17%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$751K +$699K +121,400 New
State Board of Administration of Florida Retirement System
31
State Board of Administration of Florida Retirement System
Florida
$637K
Allianz Asset Management
32
Allianz Asset Management
Germany
$620K +$173K +30,000 +43%
AllianceBernstein
33
AllianceBernstein
Tennessee
$617K -$3.36K -583 -0.6%
TA
34
Teachers Advisors
New York
$614K +$27.8K +4,831 +5%
WFM
35
Wilmington Funds Management
Delaware
$605K +$563K +97,750 New
ProShare Advisors
36
ProShare Advisors
Maryland
$467K +$73.3K +12,741 +20%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$429K +$3.06K +531 +0.8%
NFA
38
Nationwide Fund Advisors
Ohio
$423K +$78.6K +13,654 +25%
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$423K +$382K +66,300 New
OC
40
Oppenheimer & Co
New York
$422K -$128K -22,150 -25%
Swiss National Bank
41
Swiss National Bank
Switzerland
$422K -$42K -7,300 -10%
Morgan Stanley
42
Morgan Stanley
New York
$400K +$41.4K +7,196 +13%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$382K
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$380K
GCP
45
GSA Capital Partners
United Kingdom
$362K -$1.22M -211,952 -78%
AQR Capital Management
46
AQR Capital Management
Connecticut
$349K +$146K +25,400 +82%
SIM
47
Spark Investment Management
New York
$339K +$172K +29,800 +120%
Group One Trading
48
Group One Trading
Illinois
$331K -$507K -87,992 -62%
Millennium Management
49
Millennium Management
New York
$325K -$433K -75,200 -59%
AIG
50
American International Group
New York
$304K -$3.04K -529 -1%

IMMU Hedge Fund Activity: Q3 2013 in Review

83 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2013, worth a combined $208M — up 29% from $162M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 28 added to existing stakes and 28 trimmed.

The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $10.4M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $1.37M sold.

  • 83 institutional investors held Immunomedics Inc (IMMU) as of Q3 2013, up from 79 in Q2 2013.
  • Funds reported $208M of Immunomedics Inc stock for Q3 2013, up 29% quarter-over-quarter.
  • 12 funds opened new Immunomedics Inc positions in Q3 2013 and 7 closed out, a net change of +5 holders.
  • The largest Immunomedics Inc buyer in Q3 2013 was SAC Capital Advisors, an estimated $10.4M added.
  • The largest Immunomedics Inc seller in Q3 2013 was Oxford Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q3 2013.